{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T09:41:18Z","timestamp":1789897278121,"version":"4.0.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T00:00:00Z","timestamp":1377561600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s11940-013-0255-4","type":"journal-article","created":{"date-parts":[[2013,8,26]],"date-time":"2013-08-26T07:30:54Z","timestamp":1377502254000},"page":"593-606","source":"Crossref","is-referenced-by-count":48,"title":["Treatment Options for Medulloblastoma and CNS Primitive Neuroectodermal Tumor (PNET)"],"prefix":"10.1007","volume":"15","author":[{"given":"Kevin C.","family":"De Braganca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J.","family":"Packer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,27]]},"reference":[{"key":"255_CR1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/mpo.10121","volume":"39","author":"DE McNeil","year":"2002","unstructured":"McNeil DE, Cot\u00e9 TR, Clegg L, Rorke LB. Incidence and trends in pediatric malignancies medulloblastoma\/primitive neuroectodermal tumor: a SEER update. Surveillance epidemiology and end results. Med Pediatr Oncol. 2002;39:190\u20134.","journal-title":"Med Pediatr Oncol"},{"key":"255_CR2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/415436a","volume":"415","author":"SL Pomeroy","year":"2002","unstructured":"Pomeroy SL et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature. 2002;415:436\u201342.","journal-title":"Nature"},{"key":"255_CR3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00401-011-0922-z","volume":"123","author":"MD Taylor","year":"2012","unstructured":"Taylor MD et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol (Berl). 2012;123:465\u201372. Defines the four molecular subgroups of medulloblastoma and potential biologic markers.","journal-title":"Acta Neuropathol (Berl)"},{"key":"255_CR4","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S1470-2045(12)70257-7","volume":"13","author":"D Picard","year":"2012","unstructured":"Picard D et al. Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis. Lancet Oncol. 2012;13:838\u201348. Identifies subgroups of CNS PNET based on molecular analysis and reports clinical characteristics of each subgroup.","journal-title":"Lancet Oncol"},{"key":"255_CR5","unstructured":"CBTRUS (2011) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2004\u20132007. (Central Brain Tumor Registry of the United States, 2011). at <http:\/\/www.cbtrus.org\/2011-NPCR-SEER\/WEB-0407-Report-3-3-2011.pdf"},{"key":"255_CR6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00006123-199602000-00007","volume":"38","author":"AL Albright","year":"1996","unstructured":"Albright AL et al. Effects of medulloblastoma resections on outcome in children: a report from the Children\u2019s Cancer Group. Neurosurgery. 1996;38:265\u201371.","journal-title":"Neurosurgery"},{"key":"255_CR7","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1053\/j.seminoncol.2004.07.009","volume":"31","author":"BR Rood","year":"2004","unstructured":"Rood BR, Macdonald TJ, Packer RJ. Current treatment of medulloblastoma: recent advances and future challenges. Semin Oncol. 2004;31:666\u201375.","journal-title":"Semin Oncol"},{"key":"255_CR8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000071316","volume":"39","author":"RJ Packer","year":"2003","unstructured":"Packer RJ, Rood BR, MacDonald TJ. Medulloblastoma: present concepts of stratification into risk groups. Pediatr Neurosurg. 2003;39:60\u20137.","journal-title":"Pediatr Neurosurg"},{"key":"255_CR9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/jnen\/63.5.441","volume":"63","author":"CG Eberhart","year":"2004","unstructured":"Eberhart CG et al. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia. J Neuropathol Exp Neurol. 2004;63:441\u20139.","journal-title":"J Neuropathol Exp Neurol"},{"key":"255_CR10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/B978-0-444-53502-3.00007-0","volume":"105","author":"RJ Packer","year":"2012","unstructured":"Packer RJ, Macdonald T, Vezina G, Keating R, Santi M. Medulloblastoma and primitive neuroectodermal tumors. Handb Clin Neurol Ed Pj Vinken Gw Bruyn. 2012;105:529\u201348.","journal-title":"Handb Clin Neurol Ed Pj Vinken Gw Bruyn"},{"key":"255_CR11","first-page":"444","volume":"105","author":"PL Robertson","year":"2006","unstructured":"Robertson PL et al. Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children\u2019s Oncology Group. J Neurosurg. 2006;105:444\u201351.","journal-title":"J Neurosurg"},{"key":"255_CR12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3171\/2009.11.PEDS09131","volume":"5","author":"EM Wells","year":"2010","unstructured":"Wells EM et al. Postoperative cerebellar mutism syndrome following treatment of medulloblastoma: neuroradiographic features and origin. J Neurosurg Pediatr. 2010;5:329\u201334.","journal-title":"J Neurosurg Pediatr"},{"key":"255_CR13","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3171\/jns.1990.72.4.0572","volume":"72","author":"AE Evans","year":"1990","unstructured":"Evans AE et al. The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg. 1990;72:572\u201382.","journal-title":"J Neurosurg"},{"key":"255_CR14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000120264","volume":"12","author":"RJ Packer","year":"1985","unstructured":"Packer RJ, Sutton LN, D\u2019Angio G, Evans AE, Schut L. Management of children with primitive neuroectodermal tumors of the posterior fossa\/medulloblastoma. Pediatr Neurosci. 1985;12:272\u201382.","journal-title":"Pediatr Neurosci"},{"key":"255_CR15","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1200\/JCO.1999.17.3.832","volume":"17","author":"PM Zeltzer","year":"1999","unstructured":"Zeltzer PM et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children\u2019s Cancer Group 921 randomized phase III study. J Clin Oncol Off J Am Soc Clin Oncol. 1999;17:832\u201345.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"255_CR16","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1200\/JCO.2006.06.4980","volume":"24","author":"RJ Packer","year":"2006","unstructured":"Packer RJ et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol. 2006;24:4202\u20138.","journal-title":"J Clin Oncol"},{"key":"255_CR17","doi-asserted-by":"crossref","first-page":"7152","DOI":"10.1200\/JCO.2005.01.214","volume":"23","author":"M Fouladi","year":"2005","unstructured":"Fouladi M et al. Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23:7152\u201360.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"255_CR18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3747\/co.v16i6.435","volume":"16","author":"L Lafay-Cousin","year":"2009","unstructured":"Lafay-Cousin L et al. Impact of radiation avoidance on survival and neurocognitive outcome in infant medulloblastoma. Curr Oncol Tor Ont. 2009;16:21\u20138.","journal-title":"Curr Oncol Tor Ont"},{"key":"255_CR19","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.ijrobp.2010.11.081","volume":"81","author":"WR Polkinghorn","year":"2011","unstructured":"Polkinghorn WR et al. Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma. Int J Radiat Oncol. 2011;81:e15\u201320.","journal-title":"Int J Radiat Oncol"},{"key":"255_CR20","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00130404-200411000-00009","volume":"10","author":"GE Yuh","year":"2004","unstructured":"Yuh GE et al. Reducing toxicity from craniospinal irradiation: using proton beams to treat medulloblastoma in young children. Cancer J Sudbury Mass. 2004;10:386\u201390.","journal-title":"Cancer J Sudbury Mass"},{"key":"255_CR21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1651-2227.1975.tb03854.x","volume":"64","author":"S Garwicz","year":"1975","unstructured":"Garwicz S, Aronson S, Elmqvist D, Landberg T. Postirradiation syndrome and eeg findings in children with acute lymphoblastic leukaemia. Acta Paediatr Scand. 1975;64:399\u2013403.","journal-title":"Acta Paediatr Scand"},{"key":"255_CR22","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/0360-3016(84)90261-X","volume":"10","author":"P Littman","year":"1984","unstructured":"Littman P et al. The somnolence syndrome in leukemic children following reduced daily dose fractions of cranial radiation. Int J Radiat Oncol Biol Phys. 1984;10:1851\u20133.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"255_CR23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1023\/B:NEON.0000014538.31561.bc","volume":"66","author":"D Aguiar","year":"2004","unstructured":"Aguiar D et al. Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider. J Neurooncol. 2004;66:345\u201350.","journal-title":"J Neurooncol"},{"key":"255_CR24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0305-7372(03)00066-5","volume":"29","author":"BA Jereczek-Fossa","year":"2003","unstructured":"Jereczek-Fossa BA, Zarowski A, Milani F, Orecchia R. Radiotherapy-induced ear toxicity. Cancer Treat Rev. 2003;29:417\u201330.","journal-title":"Cancer Treat Rev"},{"key":"255_CR25","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ana.410320411","volume":"32","author":"J Radcliffe","year":"1992","unstructured":"Radcliffe J et al. Three- and four-year cognitive outcome in children with noncortical brain tumors treated with whole-brain radiotherapy. Ann Neurol. 1992;32:551\u20134.","journal-title":"Ann Neurol"},{"key":"255_CR26","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1001\/archneur.65.11.1419","volume":"65","author":"RJ Packer","year":"2008","unstructured":"Packer RJ, Vezina G. Management of and prognosis with medulloblastoma: therapy at a crossroads. Arch Neurol. 2008;65:1419\u201324.","journal-title":"Arch Neurol"},{"key":"255_CR27","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1200\/JCO.2005.00.703","volume":"23","author":"RK Mulhern","year":"2005","unstructured":"Mulhern RK et al. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23:5511\u20139.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"255_CR28","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","volume":"355","author":"KC Oeffinger","year":"2006","unstructured":"Oeffinger KC et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355:1572\u201382.","journal-title":"N Engl J Med"},{"key":"255_CR29","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1212\/01.wnl.0000257095.33125.48","volume":"68","author":"NJ Ullrich","year":"2007","unstructured":"Ullrich NJ et al. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology. 2007;68:932\u20138.","journal-title":"Neurology"},{"key":"255_CR30","doi-asserted-by":"crossref","first-page":"7621","DOI":"10.1200\/JCO.2005.09.095","volume":"23","author":"JR Geyer","year":"2005","unstructured":"Geyer JR et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children\u2019s Cancer Group. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23:7621\u201331.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"255_CR31","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1056\/NEJMoa042176","volume":"352","author":"S Rutkowski","year":"2005","unstructured":"Rutkowski S et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med. 2005;352:978\u201386.","journal-title":"N Engl J Med"},{"key":"255_CR32","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1002\/1097-0142(19941015)74:8<2352::AID-CNCR2820740821>3.0.CO;2-H","volume":"74","author":"C Carrie","year":"1994","unstructured":"Carrie C et al. Multivariate analysis of prognostic factors in adult patients with medulloblastoma. Retrospective study of 156 patients. Cancer. 1994;74:2352\u201360.","journal-title":"Cancer"},{"key":"255_CR33","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0360-3016(94)00476-2","volume":"32","author":"MD Prados","year":"1995","unstructured":"Prados MD et al. Medulloblastoma in adults. Int J Radiat Oncol. 1995;32:1145\u201352.","journal-title":"Int J Radiat Oncol"},{"key":"255_CR34","doi-asserted-by":"crossref","unstructured":"Chan AW et al. Adult medulloblastoma: prognostic factors and patterns of relapse. Neurosurgery. 2000;47:623\u201331. discussion 631\u2013632.","DOI":"10.1227\/00006123-200009000-00018"},{"key":"255_CR35","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/cncr.21003","volume":"103","author":"U Tabori","year":"2005","unstructured":"Tabori U et al. Medulloblastoma in the second decade of life: a specific group with respect to toxicity and management: a Canadian Pediatric Brain Tumor Consortium Study. Cancer. 2005;103:1874\u201380.","journal-title":"Cancer"},{"key":"255_CR36","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/cncr.23003","volume":"110","author":"AA Brandes","year":"2007","unstructured":"Brandes AA, Franceschi E, Tosoni A, Blatt V, Ermani M. Long-term results of a prospective study on the treatment of medulloblastoma in adults. Cancer. 2007;110:2035\u201341.","journal-title":"Cancer"},{"key":"255_CR37","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/pbc.21525","volume":"50","author":"G Dhall","year":"2008","unstructured":"Dhall G et al. Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the \u2018Head Start\u2019 I and II protocols. Pediatr Blood Cancer. 2008;50:1169\u201375.","journal-title":"Pediatr Blood Cancer"},{"key":"255_CR38","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/pbc.20781","volume":"48","author":"HK Thorarinsdottir","year":"2007","unstructured":"Thorarinsdottir HK et al. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue. Pediatr Blood Cancer. 2007;48:278\u201384.","journal-title":"Pediatr Blood Cancer"},{"key":"255_CR39","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1200\/JCO.2004.12.126","volume":"22","author":"SN Chi","year":"2004","unstructured":"Chi SN et al. Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. J Clin Oncol Off J Am Soc Clin Oncol. 2004;22:4881\u20137.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"255_CR40","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1470-2045(05)70252-7","volume":"6","author":"J Grill","year":"2005","unstructured":"Grill J et al. Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children. Lancet Oncol. 2005;6:573\u201380.","journal-title":"Lancet Oncol"},{"key":"255_CR41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1215\/15228517-2008-084","volume":"11","author":"S Rutkowski","year":"2009","unstructured":"Rutkowski S et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy. Neuro-Oncol. 2009;11:201\u201310.","journal-title":"Neuro-Oncol"},{"key":"255_CR42","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1002\/cncr.25856","volume":"117","author":"SES Leary","year":"2011","unstructured":"Leary SES, Zhou T, Holmes E, Geyer JR, Miller DC. Histology predicts a favorable outcome in young children with desmoplastic medulloblastoma: a report from the children\u2019s oncology group. Cancer. 2011;117:3262\u20137.","journal-title":"Cancer"},{"key":"255_CR43","unstructured":"McEvoy GK, Pharm.D. AHFS drug information\u00ae. (American Society of Health-System Pharmacists, Inc.)"},{"key":"255_CR44","unstructured":"Lexi-Comp Online, Pediatric & Neonatal Lexi-Drugs Online. (Lexi-Comp, Inc, 2011). at <http:\/\/online.lexi.com\/crlsql\/servlet\/crlonline>."},{"key":"255_CR45","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1200\/JCO.2008.20.1541","volume":"27","author":"DM Green","year":"2009","unstructured":"Green DM et al. Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2009;27:2677\u201385.","journal-title":"J Clin Oncol"},{"key":"255_CR46","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/pbc.22004","volume":"53","author":"ML Meistrich","year":"2009","unstructured":"Meistrich ML. Male gonadal toxicity. Pediatr Blood Cancer. 2009;53:261\u20136.","journal-title":"Pediatr Blood Cancer"},{"key":"255_CR47","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/jnci\/djn148","volume":"100","author":"BD Lawenda","year":"2008","unstructured":"Lawenda BD et al. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst. 2008;100:773\u201383.","journal-title":"J Natl Cancer Inst"},{"key":"255_CR48","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/cncr.11598","volume":"98","author":"J Bakish","year":"2003","unstructured":"Bakish J et al. Evaluation of dietetic intervention in children with medulloblastoma or supratentorial primitive neuroectodermal tumors. Cancer. 2003;98:1014\u201320.","journal-title":"Cancer"},{"key":"255_CR49","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/MPH.0b013e3181864a5e","volume":"30","author":"M Couluris","year":"2008","unstructured":"Couluris M et al. The effect of cyproheptadine hydrochloride (periactin) and megestrol acetate (megace) on weight in children with cancer\/treatment-related cachexia. J Pediatr Hematol Oncol. 2008;30:791\u20137.","journal-title":"J Pediatr Hematol Oncol"},{"key":"255_CR50","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s11060-011-0772-5","volume":"107","author":"M Bartolo","year":"2012","unstructured":"Bartolo M et al. Early rehabilitation after surgery improves functional outcome in inpatients with brain tumours. J Neurooncol. 2012;107:537\u201344.","journal-title":"J Neurooncol"},{"key":"255_CR51","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/PHM.0b013e31820be31f","volume":"90","author":"M Vargo","year":"2011","unstructured":"Vargo M. Brain tumor rehabilitation. Am J Phys Med Rehabil Assoc Acad Physiatr. 2011;90:S50\u201362.","journal-title":"Am J Phys Med Rehabil Assoc Acad Physiatr"},{"key":"255_CR52","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1200\/JCO.2003.01.202","volume":"21","author":"RJ Packer","year":"2003","unstructured":"Packer RJ et al. Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. J Clin Oncol Off J Am Soc Clin Oncol. 2003;21:3255\u201361.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"255_CR53","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11060-012-0816-5","volume":"108","author":"S Pietil\u00e4","year":"2012","unstructured":"Pietil\u00e4 S et al. Neurological outcome of childhood brain tumor survivors. J Neurooncol. 2012;108:153\u201361.","journal-title":"J Neurooncol"},{"key":"255_CR54","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/mpo.2950180410","volume":"18","author":"B Lannering","year":"1990","unstructured":"Lannering B, Marky I, Lundberg A, Olsson E. Long-term sequelae after pediatric brain tumors: their effect on disability and quality of life. Med Pediatr Oncol. 1990;18:304\u201310.","journal-title":"Med Pediatr Oncol"},{"key":"255_CR55","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/mpo.2950150505","volume":"15","author":"RJ Packer","year":"1987","unstructured":"Packer RJ, Meadows AT, Rorke LB, Goldwein JL, D\u2019Angio G. Long-term sequelae of cancer treatment on the central nervous system in childhood. Med Pediatr Oncol. 1987;15:241\u201353.","journal-title":"Med Pediatr Oncol"},{"key":"255_CR56","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/neuonc\/nos267","volume":"15","author":"RJ Packer","year":"2013","unstructured":"Packer RJ, Zhou T, Holmes E, Vezina G, Gajjar A. Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children\u2019s Oncology Group trial A9961. Neuro-Oncol. 2013;15:97\u2013103.","journal-title":"Neuro-Oncol"},{"key":"255_CR57","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (Berl). 2007;114:97\u2013109.","journal-title":"Acta Neuropathol (Berl)"},{"key":"255_CR58","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00401-012-0958-8","volume":"123","author":"M Kool","year":"2012","unstructured":"Kool M et al. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol (Berl). 2012;123:473\u201384. Retrospective analysis correlating molecular subgroups in medulloblastoma with patients characteristics and outcomes.","journal-title":"Acta Neuropathol (Berl)"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-013-0255-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-013-0255-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-013-0255-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T21:08:09Z","timestamp":1646428089000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-013-0255-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,27]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["255"],"URL":"https:\/\/doi.org\/10.1007\/s11940-013-0255-4","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,27]]}}}